Literature DB >> 8148227

Blood concentrations of dopexamine in patients during and after orthotopic liver transplantation.

P A Gray1, T Jones, G R Park.   

Abstract

Blood concentrations of dopexamine were measured in five female patients during and after orthotopic liver transplantation. Each patient received a continuous infusion of the drug (2 micrograms kg-1 min-1), starting at induction of anaesthesia and finishing 48 h afterwards. Blood concentrations of dopexamine increased rapidly at the start of the infusion, to a mean (range) value of 64 (40-150) ng ml-1 after 20 min. Blood concentrations of dopexamine increased further during the anhepatic period of surgery, to 236 (180-410) ng ml-1. On reperfusion of the donor liver, concentrations of dopexamine decreased rapidly, reaching similar values to the maximum seen during the dissection period. Steady-state was not reached during either the dissection or anhepatic periods. From 1-2 h after revascularisation the mean (range) steady-state concentration was 85 (69-102) ng ml-1 corresponding to a mean (range) clearance of 24 (20-29) ml min-1 kg -1. These results suggest that the liver plays a significant role in the clearance of dopexamine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148227      PMCID: PMC1364718          DOI: 10.1111/j.1365-2125.1994.tb04247.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation.

Authors:  A Bodenham; K Quinn; G R Park
Journal:  Br J Anaesth       Date:  1989-10       Impact factor: 9.166

2.  A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation.

Authors:  P A Gray; A R Bodenham; G R Park
Journal:  Anaesthesia       Date:  1991-08       Impact factor: 6.955

3.  Anesthesia for hepatic transplantation: cardiovascular and metabolic alterations and their management.

Authors:  F J Carmichael; M J Lindop; J V Farman
Journal:  Anesth Analg       Date:  1985-02       Impact factor: 5.108

4.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

5.  Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.

Authors:  J R Dawson; D S Thompson; M Signy; S M Juul; P Turnbull; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1985-09

6.  Extra-hepatic metabolism of midazolam.

Authors:  G R Park; A R Manara; S Dawling
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

7.  The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine.

Authors:  R J Polson; G R Park; M J Lindop; J V Farman; R Y Calne; R Williams
Journal:  Anaesthesia       Date:  1987-01       Impact factor: 6.955

8.  Splanchnic and renal contribution to disposal of infused epinephrine in humans.

Authors:  L Saccà; R Hendler; A Picardi; R S Sherwin
Journal:  Am J Physiol       Date:  1986-09
  8 in total
  1 in total

Review 1.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.